Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Abbott Laboratories (ABT) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Abbott Laboratories (ABT) - free report >>
Image: Bigstock
Company News for April 18, 2017
• Shares of Moneygram International Inc rose 7.8% after Ant Financial hiked its bid for MoneyGram, valuing the company at $1.2 billion
• Eli Lilly and Company’s (LLY - Free Report) shares declined 4.1% after the company’s drug to treat rheumatoid arthritis was rejected by Food and Drug Administration
• Shares of Ashland Global Holdings Inc. (ASH - Free Report) advanced 2% after the company agreed to purchase Pharmachem Laboratories Inc. for $660 million
• Alere Inc’s shares gained 15.9% after Abbott Laboratories (ABT - Free Report) agreed to acquire the company